|Bid||11.80 x 900|
|Ask||14.41 x 3200|
|Day's Range||13.59 - 14.23|
|52 Week Range||9.19 - 15.57|
|Beta (3Y Monthly)||0.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 30, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.33|
In 2014 Keith Dunleavy was appointed CEO of Inovalon Holdings, Inc. (NASDAQ:INOV). First, this article will compare...
Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that its Elastic Container Technology (ECT®) is now being utilized by clients on demand, providing 50x speed increases for business-critical analytical needs when requested by clients. Inovalon’s Elastic Container Technology (ECT®) allows for ultra-high performance allocation and orchestration of containerized compute processes within the Inovalon ONE® Platform. First announced by the Company on July 26, 2018, ECT® was applied within Inovalon’s more widely used analytical platform offerings to provide industry-leading process speeds across larger client populations and real-time response times for transactional applications.
The Bowie, Maryland-based company said it had a loss of 6 cents per share. Earnings, adjusted for one-time gains and costs, came to 10 cents per share. The results topped Wall Street expectations. The ...
First Quarter 2019 Highlights Q1 revenue of $145.5 million, up 57% year-over-yearQ1 net loss of $8.3 million, resulting in net loss of $0.06 per shareQ1 Non-GAAP net income of.
At Insider Monkey we follow nearly 750 of the best-performing investors and even though many of them lost money in the last couple of months of 2018 (some actually delivered very strong returns), the history teaches us that over the long-run they still manage to beat the market, which is why it can be profitable […]
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOWIE, Md., April 17, 2019 -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain t...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Inovalon Holdings, Inc. New York, April 03, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Inovalon Holdings, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
BOWIE, Md., April 01, 2019 -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced.
Data-Driven Research Presented at Academy of Managed Care Pharmacy (AMCP) and ISPOR Annual Meetings Powered by Inovalon’s MORE2 Registry® Dataset BOWIE, Md., March 28, 2019 --.
NEW YORK, March 28, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Inovalon Holdings Inc NASDAQ/NGS:INOVView full report here! Summary * Bearish sentiment is moderate Bearish sentimentShort interest | NeutralShort interest is moderate for INOV with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold INOV had net inflows of $1.41 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Inovalon (INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year engagement with Humana Inc. (HUM), a consumer-focused, technology-driven health plan known for its commitment to innovation, to implement the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for members across 17 states. Humana’s engagement will implement a broad set of modules within the Inovalon ONE® Platform ranging from capabilities for data integration, connectivity, and visualization, to advanced analytics and data-driven intervention support, to prospectively identify and predict patient gaps and improve insights into disease diagnosis, progression, documentation, and accuracy across member populations in 17 states.
BOWIE, Md., Feb. 25, 2019 -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! If you want to know who really controls Inovalon Holdings,Read More...
Inovalon Holdings (INOV) delivered earnings and revenue surprises of -44.44% and -7.05%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
BOWIE, Md. (AP) _ Inovalon Holdings Inc. (INOV) on Wednesday reported a fourth-quarter loss of $11 million, after reporting a profit in the same period a year earlier. The results did not meet Wall Street expectations. For the current quarter ending in April, Inovalon Holdings expects its per-share earnings to be 7 cents.
Full Year 2018 Highlights Full year revenue of $527.7 million, up 17% year-over-yearFull year net loss of $39.2 million, resulting in net loss of $0.27 per shareFull year.